Works matching IS 09255710 AND DT 2025 AND VI 121 AND IP 1


Results: 15
    1
    3

    A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromes.

    Published in:
    International Journal of Hematology, 2025, v. 121, n. 1, p. 68, doi. 10.1007/s12185-024-03872-3
    By:
    • Kosugi, Hiroshi;
    • Fujisaki, Tomoaki;
    • Iwasaki, Hiromi;
    • Shinagawa, Atsushi;
    • Iida, Hiroatsu;
    • Jo, Tatsuro;
    • Kubonishi, Shiro;
    • Morita, Yasuyoshi;
    • Nakashima, Yasuhiro;
    • Onodera, Koichi;
    • Suzuki, Kenshi;
    • Suzuki, Takahiro;
    • Tamai, Yotaro;
    • Usuki, Kensuke;
    • Yokota, Akira;
    • Yonaga, Hideyuki;
    • Hayakawa, Jin;
    • Midorikawa, Shuichi;
    • Nishio, Mitsufumi;
    • Suda, Makoto
    Publication type:
    Article
    4

    Association between early anti-cytomegalovirus therapy and the incidence of chronic graft-versus-host disease.

    Published in:
    International Journal of Hematology, 2025, v. 121, n. 1, p. 110, doi. 10.1007/s12185-024-03871-4
    By:
    • Miyao, Kotaro;
    • Murata, Makoto;
    • Nishida, Tetsuya;
    • Ozawa, Yukiyasu;
    • Uchida, Naoyuki;
    • Fukuda, Takahiro;
    • Doki, Noriko;
    • Eto, Tetsuya;
    • Kawakita, Toshiro;
    • Mori, Yasuo;
    • Takada, Satoru;
    • Ohigashi, Hiroyuki;
    • Tanaka, Masatsugu;
    • Kanda, Yoshinobu;
    • Matsuoka, Ken-ichi;
    • Ishimaru, Fumihiko;
    • Atsuta, Yoshiko;
    • Kanda, Junya;
    • Terakura, Seitaro
    Publication type:
    Article
    5
    6
    7

    CD34<sup>+</sup> and CD34<sup>−</sup> MM cells show different immune-checkpoint molecule expression profiles: high expression of CD112 and CD137 ligand on CD34<sup>+</sup> MM cells: High expression of CD112 and CD137ligandon CD34+multiple myeloma cells: A. Fukui-Morimoto and K. Serizawa

    Published in:
    International Journal of Hematology, 2025, v. 121, n. 1, p. 89, doi. 10.1007/s12185-024-03867-0
    By:
    • Fukui-Morimoto, Ayano;
    • Serizawa, Kentaro;
    • Fujimoto, Ko;
    • Hanamoto, Aki;
    • Iwata, Yoshio;
    • Kakutani, Hiroaki;
    • Kumode, Takahiro;
    • Hirase, Chikara;
    • Morita, Yasuyoshi;
    • Tatsumi, Yoichi;
    • Hanamoto, Hitoshi;
    • Tanaka, Hirokazu;
    • Matsumura, Itaru
    Publication type:
    Article
    8
    9
    10
    11

    Quizartinib with donor lymphocyte infusion for post-transplant relapse of FLT3-ITD-positive acute myeloid leukemia.

    Published in:
    International Journal of Hematology, 2025, v. 121, n. 1, p. 137, doi. 10.1007/s12185-024-03863-4
    By:
    • Ouchi, Fumihiko;
    • Shingai, Naoki;
    • Najima, Yuho;
    • Sadato, Daichi;
    • Hirama, Chizuko;
    • Wakita, Satoshi;
    • Kondo, Kaori;
    • Sadaga, Yasutaka;
    • Kato, Chika;
    • Sakai, Satoshi;
    • Kambara, Yasuhiro;
    • Shimabukuro, Masashi;
    • Inai, Kazuki;
    • Toya, Takashi;
    • Shimizu, Hiroaki;
    • Haraguchi, Kyoko;
    • Kobayashi, Takeshi;
    • Harada, Hironori;
    • Okuyama, Yoshiki;
    • Yamaguchi, Hiroki
    Publication type:
    Article
    12
    13
    14
    15

    A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia.

    Published in:
    International Journal of Hematology, 2025, v. 121, n. 1, p. 56, doi. 10.1007/s12185-024-03840-x
    By:
    • Sawa, Masashi;
    • Miyamoto, Toshihiro;
    • Kim, Hee-Je;
    • Hiramatsu, Yasushi;
    • Cheong, June-Won;
    • Ikezoe, Takayuki;
    • Naoe, Tomoki;
    • Akashi, Koichi;
    • Morita, Satoshi;
    • Kosako, Masanori;
    • Ikegaya, Moyu;
    • Terada, Wataru;
    • Kadokura, Takeshi;
    • Hill, Jason;
    • Miyawaki, Shuichi;
    • Gill, Stanley C.;
    • Heinloth, Alexandra;
    • Hasabou, Nahla
    Publication type:
    Article